NEW YORK (GenomeWeb News) – Vermillion today said that it has renewed a long-standing collaboration with Johns Hopkins University to develop biomarkers that can be potentially used as molecular diagnostics for cancer.
 
Under the terms of the agreement, Vermillion will have access to exclusive commercial rights to any discoveries from the partnership. Other terms of the alliance were not disclosed.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.